Cargando…
Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis
BACKGROUND: The efficacy of topical corticosteroids is limited in chronic rhinosinusitis (CRS) due to rapid clearance from the nasal cavity and insufficient drug delivery to inflamed sinonasal passages. LYR-210 is an implantable corticosteroid matrix designed to provide up to 24 weeks of treatment t...
Autores principales: | Ow, Randall A., Shotts, Steven, Kakarlapudi, Venkata, McIntyre, John, Naclerio, Robert M., You, Changcheng, Pappas, Alexander, Brayton, Lindsay, Kuang, Yina, Shao, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549255/ https://www.ncbi.nlm.nih.gov/pubmed/35708181 http://dx.doi.org/10.1177/19458924221107200 |
Ejemplares similares
-
Long‐acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study
por: Cervin, Anders, et al.
Publicado: (2021) -
Safety of intranasal corticosteroids in acute rhinosinusitis
por: Demoly, Pascal
Publicado: (2008) -
Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date
por: Kim, Jean, et al.
Publicado: (2020) -
The Treatment Paradigm of Chronic Rhinosinusitis with Nasal Polyps in the COVD-19 Era
por: Roland, Lauren T., et al.
Publicado: (2020) -
Reduced Local Response to Corticosteroids in Eosinophilic Chronic Rhinosinusitis with Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2020)